Coldstream Capital Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-699
Closed -$50.6K 3249
2025
Q1
$50.6K Buy
+699
New +$58.6K ﹤0.01% 1703
2020
Q1
Sell
-7,769
Closed -$889K 370
2019
Q4
$889K Sell
7,769
-220
-3% -$27.4K 0.07% 157
2019
Q3
$1.04M Sell
7,989
-206
-3% -$26.8K 0.09% 137
2019
Q2
$1M Sell
8,195
-126
-2% -$14.5K 0.08% 138
2019
Q1
$874K Sell
8,321
-1,791
-18% -$193K 0.08% 159
2018
Q4
$1.03M Buy
10,112
+439
+5% +$48.7K 0.1% 123
2018
Q3
$1.15M Buy
9,673
+823
+9% +$93K 0.1% 116
2018
Q2
$849K Buy
8,850
+102
+1% +$9.46K 0.09% 140
2018
Q1
$711K Buy
+8,748
New +$678K 0.08% 158

Other funds holding USPH

Coldstream Capital Management's USPH Position: Q2 2025 in Review

Coldstream Capital Management sold out of US Physical Therapy (USPH) in Q2 2025, closing a stake of 699 shares — an estimated $50.6K sold.

Coldstream Capital Management first reported a position in USPH in Q1 2018 and held it in 9 quarters. The position peaked at $1.15M in Q3 2018. 240 funds tracked by Wall St. Rank hold USPH as of Q2 2025.

  • Coldstream Capital Management reported no remaining US Physical Therapy position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 699 US Physical Therapy shares in Q2 2025, an estimated $50.6K.
  • Coldstream Capital Management first reported a position in US Physical Therapy in Q1 2018 and held it in 9 quarters.
  • Coldstream Capital Management's US Physical Therapy position peaked at $1.15M in Q3 2018.
  • 240 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.